US FDA approves Otsuka's kidney disease drug

Reuters
2025.11.25 20:10
Nov 25 (Reuters) - The U.S. Food and Drug Administration has approved Otsuka’s (4578.T) injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator’s website showed on Tuesday.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer